Dietary intake of patients with Nonalcoholic Fatty Liver Disease: Comparison between the presence and absence of Nonalcoholic Steatohepatitis and Metabolic Syndrome
Keywords:
Nutrition assessment, Nonalcoholic steatohepatitis, Fatty Liver, Eating, Insulin resistance, Metabolic syndromeAbstract
Objective
The objective of this study was to assess the food intake of individuals with Nonalcoholic Fatty Liver Disease, compare it with daily nutritional recommendations, and analyze whether diet correlates with the presence of Metabolic Syndrome and disease severity, because studies about the food habits of these individuals are still scarce in the literature.
Methods
Initially, this study assessed 158 patients diagnosed with Nonalcoholic Fatty Liver Disease. Laboratory tests, liver biopsy, anthropometric data, and food intake (determined by the three-day food record) were analyzed. Some study patients had already received dietary advice, so the sample was divided into two groups, one “without dietary advice” and another “with dietary advice”. The Student’s t-test compared the means between the groups at a significance level of 5% (α≤0.05).
Results
Of the initial sample, 59 patients changed their diet significantly after receiving dietary advice, so they were excluded from the analysis. The other 99 patients consumed 26% more energy and 80% more saturated fatty acids than recommended and presented low intake of polyunsaturated and monounsaturated fatty acids, fibers, and vitamin E, confirming previous studies in this same population. However, the diets of these patients did not differ significantly by presence or absence of Metabolic Syndrome or Nonalcoholic Steatohepatitis.
Conclusion
In light of current knowledge, these data suggest that diet, especially when high in saturated fatty acids and low in fiber and antioxidant vitamins, can play an important role in the onset of Nonalcoholic Fatty Liver Disease, but other factors play a more important role in its progression to Nonalcoholic Steatohepatitis.
References
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346(16):1221-31. http://dx.doi.org/ 10.1056/NEJMra011775
Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci. 2005; 50(1):171-80. http://dx.doi.org/10.1007/s10620-00 5-1267-z
Carvalhana S, Machado MV, Cortez-Pinto H. Improving dietary patterns in patients with nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2012; 15(5):468-73. http://dx.doi.org/ 10.1097/MCO.0b013e3283566614
Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology. 1995; 22(6):1714-9. http://dx.doi.org/10.1002/hep.1840220616
Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999; 116(6):1413-9. http://dx.doi.org/10.1016/S0016-5085(99)70506-8
Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2001; 21(1):17-26. http://dx.doi.org/10.1055/s 2001-12926
Nobili V, Carter-Kent C, Feldstein AE. The role of lifestyle changes in the management of chronic liver disease. BMC Med. 2011; 9:70. http://dx.doi.org/ 10.1186/1741-7015-9-70
Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E, Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013; 5(5):1544-60. http:// dx.doi.org/10.3390/nu5051544
Fan JG, Cao HX. Role of diet and nutritional management in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2013; 28(Suppl. 4):81-7. http://dx.doi.org/10.1111/jgh.12244
Yasutake K, Kohjima M, Kotoh K, Nakashima M, Nakamuta M, Enjoji M. Dietary habits and behaviors associated with nonalcoholic fatty liver disease. World J Gastroenterol. 2014; 20(7):1756-67. http:// dx.doi.org/10.3748/wjg.v20.i7.1756
Crispim FGS, Elias MC, Uezato N, Parise ER. Avaliação do consumo alimentar e sua relação com síndrome metabólica e gravidade da doença hepática gordurosa não alcoólica. GED. 2007; 26(S1):83.
Siebler J, Galle PR. Treatment of nonalcoholic fatty liver disease. World J Gastroenterol. 2006; 12(14):2161-7. http://dx.doi.org/10.3748/wjg.v12. i14.2161
Gill HK, Wu GY. Non-alcoholic fatty liver disease and the metabolic syndrome: Effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer? World J Gastroenterol. 2006; 12(3):345-53. http://dx.doi.org/10.3748/wjg.v12. i3.345
Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol. 1997; 27(1):103-7. http://dx.doi.org/10. 1016/S0168-8278(97)80287-5
Huang MA, Greenson JK, Chao C, Anderson L, Peterman D, Jacobson J, et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol. 2005; 100(5):1072-81. http://dx.doi.org/10.1111/ j.1572-0241.2005.41334.x
Tolman KG, Dalpiaz AS. Treatment of non-alcoholic fatty liver disease. Ther Clin Risk Manag. 2007; 3(6):1153-63.
Elias MC, Parise ER, Carvalho LD, Szejnfeld D, Netto JP. Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease. Nutrition. 2010; 26(11-12):1094-9. http://dx.doi.org/10.1016/j.nut. 2009.09.001
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. http://dx. doi.org/10.1007/BF00280883
Consenso Latino-Americano de Obesidade. Arq Bras Endocrinol Metab. 1999; 43(1):21-67. http:// dx.doi.org/10.1590/S0004-27301999000100003
Thompson FE, Byers T. Dietary assessment resource manual. J Nutr. 1994; 124(Suppl. 11):2245S-317S.
Universidade Federal de São Paulo - Escola Paulista de Medicina. NutWin: Programa de Apoio à Nutri ção. Versão 1.5. São Paulo: 2002.
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001; 285(19):2486-97. http://dx.doi.org/10.1001/jama.285.19.2486
Standards of medical care in diabetes. Diabetes Care. 2005; 28(Suppl. 1):S4-S36. http://dx.doi.org/ 10.2337/diacare.28.suppl_1.S4
Monsen ER. Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids. J Am Diet Assoc. 2000; 100(6):637-40. http://dx.doi.org/10.1016/S0002-8223(00)001 89-9
Trumbo P, Schlicker S, Yates AA, Poos M. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc. 2002; 102(11):1621-30. http://dx. doi.org/10.1016/S0002-8223(02)90346-9
Finelli C, Tarantino G. Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients? J Gastrointestin Liver Dis. 2012; 21(3):293-302.
Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003; 37(4):917-23. http://dx.doi.org/ 10.1053/jhep.2003.50161
Cortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC. Non-alcoholic fatty liver: Another feature of the metabolic syndrome? Clin Nutr. 1999; 18(6):353-8.
Loria P, Lonardo A, Carulli N. Should nonalcoholic fatty liver disease be renamed? Dig Dis. 2005; 23(1):72-82. http://dx.doi.org/10.1159/0000847 28
de Wit NJ, Afman LA, Mensink M, Müller M. Phenotyping the effect of diet on non-alcoholic fatty liver disease. J Hepatol. 2012; 57(6):1370-3. http://dx.doi.org/10.1016/j.jhep.2012.07.003
Lopes ACS, Caiaffa WT, Mingoti, SA, Lima-Costa, MFF. Ingestão alimentar em estudos epidemioló gicos. Rev Bras Epidemiol. 2003; 6(3):209-19. http:// dx.doi.org/10.1590/S1415-790X2003000300004
Fisberg RM, Martini LA, Slater B. Métodos de inquéritos alimentares. In: Fisberg RM, Slater B, Marchioni DML, Martini LA. Inquéritos alimentares: métodos e bases científicos. São Paulo: Manole; 2005. p.1-31.
Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: Implications for nonalcoholic fatty liver disease. Am J Clin Nutr. 2007; 86(2):285-300.
Cortez-Pinto H, Jesus L, Barros H, Lopes C, Moura MC, Camilo ME. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin Nutr. 2006; 25(5):816-23. http://dx.doi.org/10.1016/j. clnu.2006.01.027
Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology. 2003; 37(4):909-16. http://dx.doi.org/10.1053/ jhep.2003.50132
Bravo S, Lowndes J, Sinnett S, Yu Z, Rippe J. Consumption of sucrose and high-fructose corn syrup does not increase liver fat or ectopic fat deposition in muscles. Appl Physiol Nutr Metab. 2013; 38(6):681-8. http://dx.doi.org/10.1139/ apnm-2012-0322
Beulens JW, de Bruijne LM, Stolk RP, Peeters PH, Bots ML, Grobbee DE, et al. High dietary glycemic load and glycemic index increase risk of cardiovascular disease among middle-aged women: a population-based follow-up study. J Am Coll Cardiol. 2007; 50(1):14-21. http://dx.doi.org/10.10 16/j.jacc.2007.02.068
Clarke SD. Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription. Am J Physiol Gastrointest Liver Physiol. 2001; 281(4):G865-9.
Haque M, Sanyal AJ. The metabolic abnormalities associated with non-alcoholic fatty liver disease. Best Pract Res Clin Gastroenterol. 2002; 16(5):709-31. http://dx.doi.org/10.1053/bega.2002.0325
Yamamoto M, Iwasa M, Iwata K, Kaito M, Sugimoto R, Urawa N, et al. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2007; 22(4):498-503. http://dx.doi.org/10.1111/j.1440-1746.2006.04 548.x
Wang D, Wei Y, Pagliassotti MJ. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology. 2006; 147(2):943-51. http://dx.doi.org/10.1210/ en.2005-0570
Riccardi G, Giacco R, Rivellese AA. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr. 2004; 23(4):447-56. http://dx.doi.org/10.10 16/j.clnu.2004.02.006
Ludwig DS, Pereira MA, Kroenke CH, Hilner JE, Van Horn L, Slattery ML, et al. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. Jama. 1999; 282(16):1539-46. http://dx. doi.org/10.1001/jama.282.16.1539
McKeown NM, Meigs JB, Liu S, Wilson PW, Jacques PF. Whole-grain intake is favorably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr. 2002; 76(2):390-8.
Rocha R, Cotrim HP, Siqueira AC, Floriano S. Fibras solúveis no tratamento da Doença Hepática Gor-durosa Não-Alcoólica: estudo piloto. Arq Gas troenterol. 2007; 44(4):350-2.
Ferolla SM, Ferrari TC, Lima ML, Reis TO, Tavares-Jr WC, Couto OF, et al. Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: A cross-sectional study. Clinics (São Paulo). 2013; 68(1):11-7. http://dx.doi.org/10.6061/clinics/20 13(01)OA03
Cave M, Deaciuc I, Mendez C, Song Z, Joshi-Barve S, Barve S, et al. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. J Nutr Biochem. 2007; 18(3):184-95. http://dx.doi.org/10. 1016/j.jnutbio.2006.12.006
Allard JP, Aghdassi E, Mohammed S, Raman M, Avand G, Arendt BM, et al. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): A cross-sectional study. J Hepatol. 2008; 48(2):300-7. http://dx.doi.org/10. 1016/j.jhep.2007.09.009
Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: Pathology and pathogenesis. Annu Rev Pathol. 2010; 5:145-71. http://dx.doi.org/10. 1146/annurev-pathol-121808-102132
Villaça Chaves G, Pereira SE, Saboya CJ, Ramalho A. Non-alcoholic fatty liver disease and its relationship with the nutritional status of vitamin A in individuals with class III obesity. Obes Surg. 2008; 18(4):378-85. http://dx.doi.org/10.1007/s1 1695-007-9361-2
Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010; 362(18):1675-85. http://dx.doi. org/10.1056/NEJMoa0907929
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Fany Govetri Sena CRISPIM, Maria Cristina ELIAS, Edison Roberto PARISE
This work is licensed under a Creative Commons Attribution 4.0 International License.